BioSpace News Archive

Today, the U.S. Food and Drug Administration further assisted health care providers around the country prepare for the upcoming flu season during the COVID-19 pandemic by issuing an emergency use authorization (EUA) for the third diagnostic test for detection and differentiation of the viruses that cause flu and COVID-19 i

AVRICORE HEALTH INC. is pleased to announce that it has entered into shares for debt agreements, to satisfy an aggregate of $126,949 of the Company’s outstanding debts.

Aurora Spine Corporation announced the promotion of Chad Clouse to the position of Chief Financial Officer, effective July 2, 2020.

Transliquid Technologies LLC is voluntarily recalling all Mystic Shield Protection Topical Solution, manufactured by Mystic Intl S.A. de C.V in Mexico City, and packaged in an 8.45 ounce (250 ml) bottles, to the consumer level.

Citigroup Global Markets Inc., in its capacity as Joint Global Coordinator, notifies that the stabilization period relating to Calliditas Therapeutics AB ‘s American Depositary Shares, traded on The Nasdaq Global Select Market has ended and no further stabilization transactions will be effected.

Milestone Scientific Inc. today announced that on June 30, 2020 it closed its previously announced underwritten offering of 6,520,000 shares of its common stock and warrants to purchase up to an aggregate of 3,260,000 shares of the its common stock. Each share of common stock was sold together with a warrant to purchase 0.5

Continuous, Active Air Purifier Uses NASA-inspired ActivePure Technology

EUSA Pharma announced that the U.S. Food & Drug Administration has approved a randomized, double-blind, placebo-controlled Phase 3 clinical trial protocol to evaluate the safety and efficacy of intravenous siltuximab plus standard of care in hospitalized patients with COVID-19 associated Acute Respiratory Distress Syndrome.

Experion Holdings Ltd. is pleased to announce the results of its annual general and special meeting of the shareholders held on May 27, 2020

Theravance Biopharma, Inc. announced the appointment of Deepika R.